Parabolic Drugs Ltd. - Research Center
533211 PARABDRUGS Group (Z) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | Mar ' 16 | |
|---|---|---|---|---|---|
| Sales | - | 18.08 | 72.60 | 77.97 | 75.90 |
| Operating profit | -6.41 | -14.77 | -16.04 | -41.62 | -306.08 |
| Interest | 0.66 | 3.46 | 8.35 | 9.91 | 107.62 |
| Gross profit | -7.05 | -17.42 | -20.28 | -51.53 | -413.70 |
| EPS (Rs) | -4.63 | -6.57 | -9.14 | -17.46 | -78.40 |
Annual
results in details
| Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | Mar ' 16 | |
|---|---|---|---|---|---|
| Other income | 0.02 | 0.81 | 4.11 | - | - |
| Stock adjustment | - | 5.26 | -0.73 | 27.86 | 270.31 |
| Raw material | - | 14.73 | 64.22 | 64.08 | 58.20 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 1.68 | 5.34 | 8.88 | 8.47 | 10.68 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 4.73 | 7.52 | 16.27 | 19.18 | 42.79 |
| Provisions made | - | - | - | - | - |
| Depreciation | 21.59 | 21.77 | 34.54 | 53.49 | 67.06 |
| Taxation | - | -0.41 | 1.76 | 3.05 | 4.43 |
| Net profit / loss | -28.64 | -40.66 | -56.58 | -108.07 | -485.19 |
| Extra ordinary item | - | -1.88 | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 61.89 | 61.89 | 61.89 | 61.89 | 61.89 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | 384.96 | 379.75 |
| Agg.of non promotoholding (%) | - | - | - | 62.20 | 61.36 |
| OPM (%) | - | -81.69 | -22.09 | -53.38 | -403.27 |
| GPM (%) | - | -92.22 | -26.44 | - | - |
| NPM (%) | - | -215.25 | -73.76 | - | - |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis